Vico Therapeutics
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
$71M Series B+ ·
All 2 rounds ↓Signals
Vico Therapeutics | 469 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $71M | — | — | |
| Series B+ | undisclosed | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
GM
Gail Mandel FounderJM
Josh Mandel-Brehm Co-FounderLinkedIn · source: vicotx.comJV
Judith van Deutekom FounderLD
Luc Dochez FounderLinkedIn · source: vicotx.comAB
Anne Bechet Chief Operating OfficerGB
Gertjan Bartlema Chief Executive OfficerMM
Micah Mackison Chief Executive OfficerND
Nicole Datson Chief Development Officer
Investors
AAckermans & van Haarenlead investor
DDroia Ventures
EEQT Life Sciences
EEurazeo
KKurma Partners
PPolaris
PPureos Bioventures
SSeroba Life Sciences
Companies like Vico Therapeutics
AActio Biosciences$66M Series B+ · Jun 2025
PPretzel TherapeuticsSeries A · Sep 2022FFrontier MedicinesSeries B+ · Aug 2025
HHotSpot Therapeutics$100M Series B+ · Nov 2021
RResalis Therapeutics$10.92M Series A · Jan 2024BBloom Science$12M Series A · Dec 2021
Other companies backed by Ackermans & van Haaren
MMRM Health$64.12M Series B+ · Sep 2025
CConfo Therapeutics$65M Series B+ · Aug 2024
Ackermans & van Haaren portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vico-therapeutics (get a free API key).